Interferon deficiency can lead to severe COVID

Eric Meffre () and Akiko Iwasaki ()

Nature, 2020, vol. 587, issue 7834, 374-376

Abstract: Understanding what contributes to the development of severe COVID-19 would be of great clinical benefit. Analysis of people in whom this occurred pinpoints a key role for the signalling pathway mediated by type I interferon proteins.

Keywords: SARS-CoV-2; Immunology; Medical research (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-020-03070-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:587:y:2020:i:7834:d:10.1038_d41586-020-03070-1

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-03070-1

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().